oNKo-innate

oNKo-innate is a discovery-stage biotechnology company dedicated to target identification and preclinical immuno-oncology drug development. With a deep understanding of "natural killer" cells, they aim to be the first to truly harness the cancer-fighting capabilities of these remarkable white blood cells through therapeutic approaches.